These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8530240)

  • 1. The integration of diagnostic tests and the role of outpatient surgery in the management of breast disease.
    Ranieri E; D'Andrea MR; D'Alessio A; Bergomi S; Virno F
    Int Surg; 1995; 80(2):181-4. PubMed ID: 8530240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytology in differentiation of breast lesions.
    Ranieri E; Virno F; D'Andrea MR; Carico E; D'Alessio A; Bergomi S; Vecchione A
    Anticancer Res; 1995; 15(2):607-11. PubMed ID: 7763045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
    Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC
    G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of stereotactic guidance of breast excisional biopsy versus stereotactic core biopsy in occult breast lesions].
    Wolf G; Helbich T
    Wien Med Wochenschr; 1998; 148(14):316-20. PubMed ID: 9816641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR-mammography: current status and perspectives].
    Funke M; Fischer U; Grabbe E
    Aktuelle Radiol; 1996 May; 6(3):130-5. PubMed ID: 8679736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge.
    Liu GY; Lu JS; Shen KW; Wu J; Chen CM; Hu Z; Shen ZZ; Zhang TQ; Shao ZM
    Breast Cancer Res Treat; 2008 Mar; 108(2):271-7. PubMed ID: 17473979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant breast lesions that may mimic benign tumors.
    Weidner N
    Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraoperative histological study of nonpalpable lesions of the breast].
    Bianchi S; Vezzosi V; Palli D; Galli M; Giorgi D; Zampi G
    Chir Ital; 1995; 47(4):9-14. PubMed ID: 9005135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
    Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
    Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of clinically silent breast lesions].
    Woźniczko I; Dabrowski M; Dabrowska M; Powazka P
    Wiad Lek; 2005; 58(1-2):62-6. PubMed ID: 15991555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the diagnostic methods on the therapeutic strategies.
    Greco M; Agresti R; Giovanazzi R
    Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR-guided stereotactic breast biopsy: technical aspects and preliminary results.
    Panizza P; De Cobelli F; De Gaspari A; Gusmini S; Zanello A; Del Maschio A
    Radiol Med; 2003 Sep; 106(3):232-44. PubMed ID: 14612844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary considerations in the management of high-risk breast lesions.
    Krishnamurthy S; Bevers T; Kuerer H; Yang WT
    AJR Am J Roentgenol; 2012 Feb; 198(2):W132-40. PubMed ID: 22268202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytology in management of lesions of the breast.
    Strawbridge HT; Bassett AA; Foldes I
    Surg Gynecol Obstet; 1981 Jan; 152(1):1-7. PubMed ID: 7455882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-stop diagnosis for symptomatic breast disease.
    Gui GP; Allum WH; Perry NM; Wells CA; Curling OM; McLean A; Oommen R; Carpenter R
    Ann R Coll Surg Engl; 1995 Jan; 77(1):24-7. PubMed ID: 7717639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.